Serum and Histologic Eosinophilia as a Predictive Biomarker of Response to Mirikizumab in Ulcerative Colitis
Baseline eosinophil levels may predict response to mirikizumab and guide early treatment decisions. These findings support a potential role for eosinophils as biomarkers in UC management.
Authors
- Emily C L Wong (ORCID: https://orcid.org/0000-0001-9472-201X)
- Walter Reinisch (ORCID: https://orcid.org/0000-0002-2088-091X)
- John K. Marshall (ORCID: https://orcid.org/0000-0002-0523-9032)
- Parambir S. Dulai (ORCID: https://orcid.org/0000-0002-9514-2321)
- Neeraj Narula (ORCID: https://orcid.org/0000-0002-1536-8436)
- Vipul Jairath (ORCID: https://orcid.org/0000-0003-1590-0338)
Institutions
- Northwestern University (US)
- Western University (CA)
- Northwestern University (PH)
- Institut de Recherche en Santé Digestive (FR)
- Northwestern Medicine (US)
- Medical University of Vienna (AT)
- McMaster University (CA)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1093/ibd/izaf267
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00